tugba yalcinkaya | cancer biology | Best Researcher Award

Posted on by sciencefather

Dr. tugba yalcinkaya | cancer biology | Best Researcher Award

Dr. tugba yalcinkaya, Microbiology Reference Laboratory Department, General Directorate of Public Health, Ministry of Health, Turkey

Tuğba Yalçınkaya, a passionate cancer biology researcher, is currently a PhD candidate at Ankara Yıldırım Beyazıt University, Turkey. She earned her Master's degree in Cancer Biology from the same institution, where she also completed her undergraduate studies in Biology at Hacettepe University. With a strong foundation in molecular biology and cell culture, Tuğba has worked extensively in the field of cancer research, particularly focusing on the mechanisms of apoptosis and cell cycle regulation in cancer cells. She is currently a Biologist at the Republic of Turkey Ministry of Health, where she applies her expertise in laboratory management and molecular analysis. Tuğba has published in notable journals and presented her findings at various international conferences. Her work aims to contribute significantly to the development of potential cancer therapies, making her a valuable asset to the scientific community.

Professional Profile 

Scopus

Orcid

Summary for the Research for Best Researcher Award: Tuğba Yalçınkaya

Tuğba Yalçınkaya stands out as a highly qualified candidate for the Research for Best Researcher Award due to her extensive academic background, practical experience, and contributions to cancer biology research. Her dedication to advancing scientific knowledge is evident from her work with the Republic of Turkey Ministry of Health, where she has contributed as both a biologist and office manager. Since 2021, she has demonstrated expertise in molecular biology techniques, including gene expression analysis, cytotoxicity assays, and apoptosis evaluations. This solid foundation in laboratory-based research aligns with the award's emphasis on significant academic contributions.

Her educational journey, culminating in a Ph.D. in Cancer Biology from Ankara Yıldırım Beyazıt University (expected in 2025), combined with a Master of Science degree and a Bachelor's degree in Biology, further reinforces her qualifications. Tuğba's active participation in prestigious workshops and training, such as the Single-Cell Sequencing Workshop and Next-Generation Sequencing and Bioinformatics for Molecular Surveillance, highlights her commitment to staying at the forefront of scientific advancements.

  Education 

Tuğba Yalçınkaya's academic journey began with a Bachelor of Science in Biology from Hacettepe University, Ankara, where she laid the groundwork for her future in scientific research. She then pursued a Master of Science in Cancer Biology at Ankara Yıldırım Beyazıt University, where she explored the molecular aspects of cancer, focusing on apoptosis and cell cycle studies. Tuğba's passion for cancer research led her to continue her academic path by enrolling in a PhD program at Ankara Yıldırım Beyazıt University in Cancer Biology. Her doctoral research aims to deepen the understanding of cancer biology, particularly through the examination of potential anticancer agents. Throughout her academic career, Tuğba has participated in various specialized workshops and courses, including training in PCR, real-time PCR, and single-cell sequencing, enhancing her laboratory skills and expanding her scientific knowledge.

Professional Experience

Tuğba Yalçınkaya has garnered extensive experience in the field of cancer research and molecular biology. Since 2021, she has been working as a Biologist at the Republic of Turkey Ministry of Health, where she conducts research on cancer and other biomedical topics. In this role, she is responsible for designing and conducting experiments, analyzing results, and managing laboratory processes. Prior to this, Tuğba served as an Office Manager at the Ministry of Health from 2013 to 2021, where she honed her organizational and managerial skills, ensuring the smooth operation of research activities. Her career path has provided her with both leadership and hands-on laboratory experience, making her highly skilled in coordinating research projects, adhering to protocols, and maintaining high standards in experimental work. Tuğba's expertise is crucial in advancing cancer biology research at both the molecular and clinical levels.

 Awards and Recognition 

Tuğba Yalçınkaya has earned numerous certifications and accolades throughout her career, recognizing her contributions to cancer research. She holds a certificate for "Experimental Animals Use" from the Ministry of Health's Turkish Medicines and Medical Devices Agency and participated in a "Single-Cell Sequencing Workshop" in 2024. Tuğba’s academic excellence is also reflected in her recognition as a presenter at international conferences, including the "2nd International Congress on Stem Cell and Cellular Therapies" and the "10th ISMRC International Symposium on Minimal Residual Cancer." Her research findings have been published in respected journals such as Toxicon and Turk Hij Den Biyol Derg, showcasing her expertise in cancer biology and related fields. Tuğba has been commended for her commitment to advancing cancer research and her innovative approach to studying the molecular mechanisms of cancer therapies, making her a respected figure in the scientific community.

Research Skills On cancer biology

Tuğba Yalçınkaya has developed a comprehensive set of research skills that are pivotal to her work in cancer biology. She is proficient in a wide array of laboratory techniques, including PCR, RT-PCR, real-time PCR, DNA/RNA isolation, cell culture, and apoptosis analysis. Tuğba's expertise extends to cytotoxicity assays, where she evaluates the effects of various agents on cancer cell lines. Additionally, her research includes the investigation of bacterial toxins and their potential as anticancer agents, focusing on their effects on DNA repair mechanisms and the cell cycle. Tuğba also possesses significant experience in bioinformatics, specifically in analyzing high-throughput sequencing data. Her ability to synthesize complex data and interpret experimental results enables her to draw meaningful conclusions that drive her research forward. Her organizational and leadership skills further enhance her ability to manage research projects efficiently, ensuring they meet the highest scientific standards.

  Publication Top Notes

  • Investigation of Natural Diphtheria Toxin as a Potential Anticancer Agent in Colorectal Cancer: An in vitro Analysis on HT-29 Cells
    Journal: Toxicon
    Year: 2025
    Authors: Tugba YALCINKAYA, Ahmet CARHAN

  • Ficus carica extract causes cell cycle arrest and induces apoptosis in MG-63 and HT-29 cancer cell lines, Ficus carica ekstraktı, hücre döngüsünün durmasına neden olur ve MG-63 ve HT-29 kanser hücre hatlarında apoptozu indükler
    Journal: Turk Hijyen ve Deneysel Biyoloji Dergisi
    Year: 2023
    Authors: Yalçinkaya, T.; Kozaci, L.D.; Çarhan, A.

  • Digital PCR and applications, Dijital PZR ve kullanim alanlari
    Journal: Turk Hijyen ve Deneysel Biyoloji Dergisi
    Year: 2016

Muhammad Zeeshan Bhatti | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Muhammad Zeeshan Bhatti | Medicinal Chemistry | Best Researcher Award

Assist. Prof. Dr. Muhammad Zeeshan Bhatti, National University of Medical Sciences, Pakistan 

Dr. Muhammad Zeeshan Bhatti is an accomplished researcher and Assistant Professor at the Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan. With a specialization in biochemistry and molecular biology, he has dedicated his career to advancing the fields of cancer therapeutics, Medicinal Chemistry, and antimicrobial resistance. Dr. Bhatti’s research primarily focuses on anticancer drug discovery, investigating the molecular mechanisms of natural and synthetic compounds. He is known for his expertise in phytochemical and pharmacological studies of medicinal plants, contributing significantly to the understanding of anticancer and antimicrobial mechanisms. Holding a PhD from East China Normal University, he brings an international perspective to his work, making a profound impact through various high-impact publications and groundbreaking research projects aimed at improving human health.

Professional Profile

scopus

orcid

google scholar

Summary of Suitability for the Research for Best Researcher Award

Dr. Muhammad Zeeshan Bhatti demonstrates a strong academic and research background that positions him as a noteworthy candidate for the Research for Best Researcher Award. With a focus on biochemistry, molecular biology, and cancer therapeutics, his work targets high-impact areas in health and pharmaceutical sciences, particularly anticancer drug discovery and mechanisms of action for natural and synthetic compounds. His expertise extends into medicinal chemistry and antimicrobial resistance, essential fields given global health challenges. Dr. Bhatti’s research on phytochemicals and pharmacology, as well as his studies in nanotechnology for medicinal applications, further underscores his dedication to innovative and multidisciplinary scientific exploration.

 🎓 Education

Dr. Muhammad Zeeshan Bhatti holds a Doctorate in Biochemistry and Molecular Biology (PhD), earned from the Institute of Biomedical Sciences, East China Normal University, Shanghai, China, from 2013 to 2017. Prior to his PhD, he completed his Master of Philosophy (M.Phil) in Biochemistry and Molecular Biology at Quaid-i-Azam University, Islamabad, Pakistan (2010-2012), where he delved into molecular biology concepts fundamental to his career. His journey in scientific academia began with a Master of Science (M.Sc) in Biology from Gomal University, Dera Ismail Khan, Pakistan, where he developed a strong foundation in biological sciences. He earned his Bachelor of Science (B.Sc) from Government Degree College No.1, Gomal University, Dera Ismail Khan, Pakistan, equipping him with essential skills that have shaped his impactful career in medicinal research.

💼 Professional Experience

Dr. Bhatti is currently an Assistant Professor at the Department of Biological Sciences, National University of Medical Sciences (NUMS), Rawalpindi, Pakistan. He joined NUMS in April 2019, initially in an ad-hoc capacity, before transitioning to a tenure-track role. His experience spans across both academic and research capacities, where he guides graduate students and collaborates on research projects. Dr. Bhatti’s notable projects include the green synthesis of nanoparticles, anticancer studies on ruthenium complexes, and exploring the effects of vitamin B6 complexes on cancer cells. He has taken on various roles as Principal Investigator in multiple projects funded by prestigious national research grants. His commitment to education and innovation within the biological sciences demonstrates his dedication to advancing research and scientific knowledge in medicinal chemistry.

🏅   Awards and Recognitions

Dr. Bhatti has been recognized for his pioneering work in medicinal chemistry and biochemistry. His awards include grants from the Higher Education Commission of Pakistan (HEC) for significant research projects, such as studies on cancer therapeutics and nanoparticle synthesis using medicinal plants. His achievements also include awards for publishing impactful research in international journals and for his innovative contributions to cancer research. Dr. Bhatti’s expertise in phytochemistry and pharmacology has earned him prestigious roles as a principal investigator in multi-year funded projects, further establishing him as a leading figure in his field. His contributions have strengthened Pakistan’s academic and scientific landscape in biochemistry and molecular biology.

🌍  Research Skills

Dr. Bhatti possesses a versatile skill set in biochemistry, molecular biology, and medicinal chemistry, focusing on anticancer drug discovery. His research expertise includes designing and synthesizing molecules, exploring the molecular mechanisms of action for both natural and synthetic compounds, and conducting pharmacological studies on medicinal plants. With a specialized focus on the molecular pathways of cancer therapeutics, he also investigates antimicrobial resistance. Proficient in advanced molecular and cellular biology techniques, Dr. Bhatti’s skills extend to phytochemical analyses and the biological activity assessment of compounds. His comprehensive understanding of these research skills drives his innovative contributions to biochemistry and medicinal chemistry.

📖 Publication Top Notes

Title: Antioxidant and phytochemical analysis of Ranunculus arvensis L. extracts
  • Authors: MZ Bhatti, A Ali, A Ahmad, A Saeed, SA Malik
    Journal: BMC Research Notes
    Cited by: 107
    Year: 2015
Title: Dimetallic Ru (II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling
  • Authors: FU Rahman, MZ Bhatti, A Ali, HQ Duong, Y Zhang, X Ji, Y Lin, H Wang, …
    Journal: European Journal of Medicinal Chemistry
    Cited by: 39
    Year: 2018
Title: ONS-donor ligand based Pt (II) complexes display extremely high anticancer potency through autophagic cell death pathway
  • Authors: FU Rahman, A Ali, HQ Duong, IU Khan, MZ Bhatti, ZT Li, H Wang, …
    Journal: European Journal of Medicinal Chemistry
    Cited by: 31
    Year: 2019
Title: Tumor-suppressive p53 signaling empowers metastatic inhibitor KLF17-dependent transcription to overcome tumorigenesis in non-small cell lung cancer
  • Authors: A Ali, MZ Bhatti, AS Shah, HQ Duong, HM Alkreathy, SF Mohammad, …
    Journal: Journal of Biological Chemistry
    Cited by: 30
    Year: 2015
Title: Acylhydrazone as a novel “off–on–off” fluorescence probe for the sequential detection of Al³⁺ and F⁻
  • Authors: YP Wu, FU Rahman, MZ Bhatti, SB Yu, B Yang, H Wang, ZT Li, DW Zhang
    Journal: New Journal of Chemistry
    Cited by: 26
    Year: 2018